Kevin St. P. McNaught

7.2k total citations · 2 hit papers
41 papers, 5.6k citations indexed

About

Kevin St. P. McNaught is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Kevin St. P. McNaught has authored 41 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 14 papers in Molecular Biology. Recurrent topics in Kevin St. P. McNaught's work include Parkinson's Disease Mechanisms and Treatments (28 papers), Ubiquitin and proteasome pathways (10 papers) and Neurological diseases and metabolism (7 papers). Kevin St. P. McNaught is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (28 papers), Ubiquitin and proteasome pathways (10 papers) and Neurological diseases and metabolism (7 papers). Kevin St. P. McNaught collaborates with scholars based in United States, United Kingdom and Switzerland. Kevin St. P. McNaught's co-authors include C. Warren Olanow, Peter Jenner, Ole Isacson, Peter Jenner, Daniel P. Perl, Roger Belizaire, Anna‐Liisa Brownell, P. Shashidharan, Anna-Liisa Brownell and Bruce G. Jenkins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature reviews. Neuroscience.

In The Last Decade

Kevin St. P. McNaught

40 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

2002 890 citations Kevin St. P. McNaught, Ole Isacson et al. profile →
Proteasomal function is impaired in substantia nigra in Parkinson's disease

2001 538 citations Kevin St. P. McNaught, Peter Jenner Neuroscience Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin St. P. McNaught United States	31	3.0k	2.4k	2.3k	1.1k	872	41	5.6k
Frank Gillardon Germany	37	1.5k 0.5×	2.2k 0.9×	1.5k 0.6×	1.0k 1.0×	499 0.6×	98	4.6k
Penelope J. Hallett United States	36	1.7k 0.6×	2.1k 0.9×	1.9k 0.8×	1.1k 1.0×	505 0.6×	63	4.2k
Dagmar Galter Sweden	39	1.4k 0.5×	2.8k 1.1×	1.7k 0.7×	1.1k 1.0×	384 0.4×	76	5.6k
Natalia Ninkina United Kingdom	38	2.1k 0.7×	1.8k 0.7×	1.4k 0.6×	988 0.9×	443 0.5×	103	4.3k
Baptiste Faucheux France	40	3.2k 1.1×	3.0k 1.2×	3.7k 1.6×	1.1k 1.0×	392 0.4×	90	7.4k
Francesca Cicchetti Canada	47	2.4k 0.8×	2.7k 1.1×	3.3k 1.4×	898 0.8×	292 0.3×	138	6.4k
Yaping Chu United States	39	4.1k 1.4×	2.8k 1.2×	4.1k 1.8×	1.7k 1.6×	440 0.5×	70	8.2k
Paul T. Kotzbauer United States	31	2.1k 0.7×	2.1k 0.9×	1.6k 0.7×	1.8k 1.7×	472 0.5×	52	5.2k
Minh Dang Nguyen Canada	32	1.5k 0.5×	2.5k 1.0×	1.1k 0.5×	940 0.9×	557 0.6×	70	5.7k
Sheela Vyas France	26	1.4k 0.5×	1.5k 0.6×	1.5k 0.7×	665 0.6×	328 0.4×	41	4.0k

Countries citing papers authored by Kevin St. P. McNaught

Since Specialization

Citations

This map shows the geographic impact of Kevin St. P. McNaught's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin St. P. McNaught with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin St. P. McNaught more than expected).

Fields of papers citing papers by Kevin St. P. McNaught

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin St. P. McNaught. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin St. P. McNaught. The network helps show where Kevin St. P. McNaught may publish in the future.

Co-authorship network of co-authors of Kevin St. P. McNaught

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin St. P. McNaught. A scholar is included among the top collaborators of Kevin St. P. McNaught based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin St. P. McNaught. Kevin St. P. McNaught is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Black, Kevin J., Joseph Jankovic, Tamara Hershey, et al.. (2014). Progress in research on Tourette syndrome. Journal of Obsessive-Compulsive and Related Disorders. 3(4). 359–362. 11 indexed citations

McNaught, Kevin St. P. & Jonathan W. Mink. (2011). Advances in understanding and treatment of Tourette syndrome. Nature Reviews Neurology. 7(12). 667–676. 110 indexed citations

McNaught, Kevin St. P., et al.. (2009). The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease. Synapse. 64(3). 241–250. 30 indexed citations

Olanow, C. Warren & Kevin St. P. McNaught. (2006). Ubiquitin–proteasome system and Parkinson's disease. Movement Disorders. 21(11). 1806–1823. 156 indexed citations

McNaught, Kevin St. P., et al.. (2006). Proteasomal dysfunction in sporadic Parkinson's disease. Neurology. 66(10_suppl_4). S37–49. 48 indexed citations

McNaught, Kevin St. P. & C. Warren Olanow. (2005). Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease. Neurobiology of Aging. 27(4). 530–545. 130 indexed citations

McNaught, Kevin St. P., Alexander Kapustin, P. Shashidharan, et al.. (2004). Brainstem pathology in DYT1 primary torsion dystonia. Annals of Neurology. 56(4). 540–547. 104 indexed citations

McNaught, Kevin St. P., Daniel P. Perl, Anna‐Liisa Brownell, & C. Warren Olanow. (2004). Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Annals of Neurology. 56(1). 149–162. 398 indexed citations

Olanow, C. Warren, Daniel P. Perl, George Demartino, & Kevin St. P. McNaught. (2004). Lewy-body formation is an aggresome-related process: a hypothesis. The Lancet Neurology. 3(8). 496–503. 232 indexed citations

10.

McNaught, Kevin St. P., et al.. (2002). Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport. 13(11). 1437–1441. 211 indexed citations

11.

McNaught, Kevin St. P., P. Shashidharan, Daniel P. Perl, Peter Jenner, & C. Warren Olanow. (2002). Aggresome‐related biogenesis of Lewy bodies. European Journal of Neuroscience. 16(11). 2136–2148. 207 indexed citations

12.

McNaught, Kevin St. P., et al.. (2002). Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. Journal of Neurochemistry. 81(2). 301–306. 248 indexed citations

13.

McNaught, Kevin St. P., C. Warren Olanow, Barry Halliwell, Ole Isacson, & Peter Jenner. (2001). Failure of the ubiquitin–proteasome system in Parkinson's disease. Nature reviews. Neuroscience. 2(8). 589–594. 402 indexed citations

14.

McNaught, Kevin St. P. & Peter Jenner. (2000). Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation. Biochemical Pharmacology. 60(7). 979–988. 74 indexed citations

15.

McNaught, Kevin St. P. & Peter Jenner. (1999). Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures. Journal of Neurochemistry. 73(6). 2469–2476. 111 indexed citations

16.

McNaught, Kevin St. P., Pierre‐Alain Carrupt, Cosimo Altomare, et al.. (1998). Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson’s disease. Biochemical Pharmacology. 56(8). 921–933. 87 indexed citations

17.

McNaught, Kevin St. P., Ulrike Thull, Pierre‐Alain Carrupt, et al.. (1996). Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience Letters. 206(1). 37–40. 24 indexed citations

18.

McNaught, Kevin St. P., Ulrike Thull, Pierre‐Alain Carrupt, et al.. (1996). Nigral Cell Loss Produced by Infusion of Isoquinoline Derivatives Structurally Related to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine. PubMed. 5(3). 265–274. 20 indexed citations

19.

McNaught, Kevin St. P., Cosimo Altomare, Saverio Cellamare, et al.. (1995). Inhibition of α-Ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroreport. 6(8). 1105–1108. 36 indexed citations

20.

Thull, Ulrike, Patrick Gaillard, Pierre‐Alain Carrupt, et al.. (1995). Inhibition of monoamine oxidase by isoquinoline derivatives. Biochemical Pharmacology. 50(6). 869–877. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact